Concepedia

Georges Weissgerber

GW

Statistics

Publications

14

Citations

1K

H-Index

13

Active since

1997

Affiliations

Novartis (Switzerland)(Current)

University of Bonn

Pfizer (United Kingdom)

Retinal Consultants of Arizona

Medical University of Vienna

Georges Weissgerber is an author at Novartis (Switzerland) specializing in medicine, pharmacology, and ophthalmology.

Publications per year

1997–2022

14

Publications

14

HAWK and HARRIER

Pravin U. Dugel, Rishi P. Singh, Adrian Koh et al. · Ophthalmology · 2020 · 371 citations

, , +17

Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration

Frank G. Holz, Pravin U. Dugel, Georges Weissgerber et al. · Ophthalmology · 2016 · 184 citations · Full text

, , +17

Activation of protein kinase C subtypes α, γ, δ, ϵ, ζ, and η by tumor-promoting and nontumor-promoting agents

Detlef Geiges, Thomas Meyer, Barbara Marte et al. · Biochemical Pharmacology · 1997 · 87 citations

, , +14

Cognitive testing in early-phase clinical trials: Development of a rapid computerized test battery and application in a simulated Phase I study

Alex Collie, Amanda Darekar, Georges Weissgerber et al. · Contemporary Clinical Trials · 2006 · 85 citations

, , +17

Efficacy and safety of brolucizumab versus aflibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants of HAWK

Yuichiro Ogura, Glenn J. Jaffe, Chui Ming Gemmy Cheung et al. · British Journal of Ophthalmology · 2021 · 70 citations · Full text

, , +17

1–5 of 14